Skip to main content
Global Edition
Saturday, April 27, 2024

Health Headlines - 8-13-20

Credit: FOX 47 News Michigan
Duration: 02:03s 0 shares 1 views

Health Headlines - 8-13-20
Health Headlines - 8-13-20

In today's health headlines we talk about other therapies for COVID-19 beyond just vaccines.

VACCINES FOR COVID-19 HAVE BEENGETTING A LOT OF ATTENTION BUTOTHER DRUGCOMPANIES ARE RACING TO DEVELOPTHERAPIES THAT COULD BEAVAILABLE SOONERTHAN VACCINES.MEG TIRRELL HAS THE DETAILS.44-YEAR OLD JASON BARTON HADJUST RETURNED TO ARIZONA FROM AFAMILY TRIP WHEN HE GOT APOUNDINGHEADACHE.TESTING REVEALED HE , HIS WIFEAND TWO KIDS, AND HIS MOM ANDSTEPDAD BACK IN TENNESSEE ALLHAD THECORONAVIRUS.:15SOT JASON BARTON/PATIENT"IT WAS MOSTLY JUST HEADACHES.24 HOURS A DAY FOR TWO WEEKSSTRAIGHT."BARTON ENTERED A CLINICAL TRIALOF A NEW KIND OF DRUG TO TREATCOVID-19.:24SOT DR. ANITA KOHLI/ARIZONACLINICAL TRIALS "THIS IS A CLASSOF DRUGS THAT WORKS BY BY GIVINGPEOPLE ANTIBODIES THAT WILL HELPFIGHT THE VIRUS."IN DEVELOPMENT FROM REGENERONAND ELI LILLY, THE ANTIBODIESARE DERIVED FROM PEOPLE WHO'VERECOVERED FROM COVID-19.

ANDREGENERON HAS COMBINED ONE OFTHOSE ANTIBODIES WITHONE IT DEVELOPED IN ITS LABS.WHILE THE DRUGS ARE BEING TESTEDTO TREAT THE DISEASE ADIFFERENT KIND OF TRIAL HASSTARTED AS WELL, DESIGNED TO SEEIF THEY CAN PREVENT IT INPEOPLEWHO MIGHT HAVE BEEN EXPOSED.:53SOT GEORGE YANCOPOULOS/REGENERONCHIEF SCIENTIFIC OFFICER"THERE'S A LOT OF REASONS A LOTOF EVIDENCE TO SUGGEST THAT IFYOU TREAT BEFORE INFECTION FORMOST OF THESE DISEASES, BUTINCLUDING COVID, YOU CANENTIRELY PREVENT THE INFECTION."APRIL STEWART ENROLLED IN ONE OFTHOSE TRIALS AFTER HER SON WASDIAGNOSED WITH COVID-19.1:12SOT APRIL STEWART/CLINICAL TRIALPARTICIPANT"THIS WHOLE THING IS SCARY.

ANDI WAS THANKFUL THAT NOBODY ELSEIN MY HOUSEHOLD HAD COMEDOWN WITH COVID."THE PREVENTION TRIALS ARE BEINGRUN IN PARTNERSHIP WITH THENATIONAL INSTITUTE OF ALLERGYAND INFECTIOUS DISEASES.REGENERON'S IS ENROLLINGHOUSEMATES OF PEOPLE WITHCOVID-19,WHILE ELI LILLY'S WILL GO TONURSING HOMES THAT HAVE HADOUTBREAKS.RESEARCHERS ARE EAGER FOR PEOPLETO ENROLL IN THE TRIALS.SOT DR. ANITA KOHLI/ARIZONACLINICAL TRIALS"IT'S THE ONLY WAY WE'RE GOINGTO GET DATA ON THESE DRUGS ABOUTWHETHER THEY WORK ORNOT AND DEVELOP AN OPTION FORPATIENTS AND EVENTUALLY GET BACKTO A TO A NORMAL LIFE."JASON SAYS HE FELT BETTER A FEWDAYS AFTER GETTING THE TRIAL.APRIL HASN'T COME DOWN WITHCOVID... BUT NEITHER KNOWS IFTHEY REALLY

You might like

Related news coverage

Advertisement

More coverage